Outcome of Board Meeting - Board of Directors of Novartis India Limited (the "Company") approves transfer of OTC Division
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 13, 2015, has approved transfer of its OTC Division to the consumer healthcare joint venture between Novartis AG and GSK. Novartis India Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Novartis India Ltd with respect to news article appearing in The Economic Times on December 24, 2014 titled "CCI gives approval for Novartis-GSK Pharma Deal"Novartis India Ltd replied stating "Novartis AG and GSK plc have agreed to create a consumer healthcare business through a global joint venture between the OTC division of Novartis and the consumer healthcare division of GSK. The global transaction... Clarification sought from Novartis India Ltd
The Exchange has sought clarification from Novartis India Ltd with respect to news article appearing in The Economic Times on December 24, 2014 titled "CCI gives approval for Novartis-GSK Pharma Deal." The reply is awaited. Outcome of Board Meeting
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 07, 2014, inter alia, has approved transfer of Animal Health Division. Financial Results with Results Press Release & Limited Review for Sept 30, 2014 (Standalone)
Novartis India Ltd has informed BSE about the Standalone Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended September 30, 2014. Clarification from Novartis India Ltd
The Exchange has sought clarification from Novartis India Ltd with respect to news article appearing in Business Standard on October 13, 2014 titled "NPPA slaps 300 cr. Penalty on Novartis."Novartis India Ltd has Clarified to BSE as under :"Novartis has received a notice from NPPA and will duly respond to the same. Novartis believes the show cause notice to be erroneous and entirely misconceived and Novartis will challenge both the... Clarification sought from Novartis India Ltd
The Exchange has sought clarification from Novartis India Ltd with respect to news article appearing in Business Standard on October 13, 2014 titled "NPPA slaps 300 cr. Penalty on Novartis."The reply is awaited. Shareholding Pattern For September 30, 2014
Novartis India Ltd has informed BSE about the Shareholding Pattern as on September 30, 2014. Disclosure of Voting results of AGM (Clause 35A)
Novartis India Ltd has informed BSE regarding the details of Voting results at the Annual General Meeting of the Company held on July 25, 2014, under Clause 35A. Outcome of AGM
Novartis India Ltd has informed BSE that the Annual General Meeting (AGM) of the Company was held on July 25, 2014.